Systemic manifestations of gnathostomiasis can affect the skin, brain, gastrointestinal tract and respiratory system, while ocular involvement is rare. 5 Intraocular gnathostomiasis, though uncommon, ...

1–3 The possibility of harmful effects is ... to the history and physical examination. Pentobarbital, 100 mg., and atropine, 0.6 mg., were administered intramuscularly approximately forty ...

After premedication with pentobarbital, atropine or scopolamine and morphine ... by the continuous intravenous infusion of 1.1 to 9.2 mg. of succinylcholine di-iodide per minute.

1 Department of Anesthesiology ... If residual neuromuscular blockade persisted, it was reversed with neostigmine (0.03 mg/kg) and atropine (0.03 mg/kg), with additional doses administered as needed.

The Food and Drug Administration (FDA) has accepted for review the New Drug Application (NDA) for SYD-101 (atropine sulfate) to slow the progression of ...

The FDA has set a PDUFA target action date of October 23, 2025, for the low-dose atropine formulation.